INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Investments Management, LLC | 82,696 | $959,000 | 1.05% |
| Defender Capital, LLC. | 119,914 | $1,391,000 | 0.68% |
| Bayesian Capital Management, LP | 171,200 | $1,986,000 | 0.48% |
| Enlightenment Research, LLC | 13,800 | $160,000 | 0.47% |
| Harvest Investment Services, LLC | 47,558 | $551,000 | 0.32% |
| WASATCH ADVISORS LP | 3,383,001 | $39,243,000 | 0.25% |
| Cedar Brook Financial Partners, LLC | 54,900 | $637,000 | 0.25% |
| Monaco Asset Management SAM | 33,900 | $393,000 | 0.23% |
| Coatue Management | 3,576,923 | $41,492,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 124,884 | $1,449,000 | 0.22% |